| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
帕瑞昔布钠杂质18 |
198471-06-6 |
| Parecoxib Impurity T |
Parecoxib Impurity T |
198471-83-9 |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide |
帕瑞昔布杂质 |
198470-82-5 |
| Parecoxib ImpurityO |
帕瑞昔布钠杂质O |
198470-91-6 |
| 4-bromo-1,2,6,7-tetrahydro-8H-Indeno[5,4-b]furan-8-one |
4-bromo-1,2,6,7-tetrahydro-8H-Indeno[5,4-b]furan-8-one |
196597-69-0 |
| 4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoroMethyl)propylidene]aMino]benzenesulfonaMide |
4-[[3-(4-甲基苯基)-3-氧代-1-(三氟甲基)亚丙基]氨基]苯磺酰胺 |
1061214-09-2 |
| (3R,5R)-Fluvastatin Sodium Salt |
(3R,5R)-氟伐他汀钠盐 |
194934-99-1 |
| (3aR,4R,7S,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride |
LURASIDONE ISOMER (R,R-ENDO) |
194861-74-0 |
| tert-Butyl (E)-3,5-Dihydroxy-7-[3'-(4"-fluorophenyl)-1'-methylethylindol-2'-yl)hept-6-enoate |
(E)-3,5-二羟基-7-[3'-(4"-氟苯基)-1'-(1"-甲基乙基)吲哚-2'-基]-6-庚烯酸叔丁酯 |
194934-96-8 |
| (3S,5S)-Fluvastatin Sodium Salt |
(3S,5S)-氟伐他汀钠盐 |
194935-01-8 |
| Ganciclovir Monoproprionate |
更昔洛韦单-O-丙酸酯 |
194159-18-7 |
| Meropenem IMP A |
美罗培南杂质A |
1053703-36-8 |
| 3-Des(1-ethylpropoxy)-3-(1-Methylpropoxy) OseltaMivir |
(3R,4R,5S)-4-(乙酰氨基)-5-氨基-3-(1-甲基丙氧基)-1-环己烯-1-羧酸乙酯 |
1052063-37-2 |
| Ropivacaine-iPr-R |
罗哌卡因杂质 |
1050482-18-2 |
| 3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one |
奥美沙坦酯杂质G |
1048948-15-7 |
| EZM-K |
(3R,4S)-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]-4-(4-羟基苯基)氮杂环丁烷-2-酮 |
191330-56-0 |
| 3-(2-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL |
2-三氟甲基苯丙醇 |
191155-81-4 |
| Pitavastatin Impurity 8 |
匹伐他汀杂质8 |
1044518-75-3 |
| EzetiMibe IMpurity 1 |
依折麦布杂质1 |
190595-66-5 |
| ent-montelukast sodium salt |
孟鲁司特EP杂质A |
190078-45-6 |
QQ
微信
